Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 7, 2008, Pages 483-491

  Takeshita, Masao ^a   Katsuragi, Yoshihisa ^a   Kusuhara, Masatoshi ^b   Higashi, Kenji ^b   Miyajima, Emiko ^c   Mizuno, Kyoichi ^d   Mori, Kenta ^a   Obata, Tatsuo ^b   Ohmori, Reiko ^b   Ohsuzu, Fumitaka ^b   Onodera, Yoshimitsu ^e   Sano, Junko ^d   Sawada, Shojiro ^b   Tabata, Shinji ^b   Tokimitsu, Ichiro ^a   Tomonobu, Kazuichi ^a   Yamashita, Takeshi ^c   Yasukawa, Takuji ^a   Yonemura, Atsushi ^b   Nakamura, Haruo ^c  

^a KAO CORPORATION   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c Mitsukoshi Health and Welfare Foundation   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e Nikko Memorial Hospital   (Japan)

Author keywords

Diacylglycerol; Hypercholesterolemia; Phytosterols; Pravastatin

Indexed keywords

CHOLESTEROL; DIACYLGLYCEROL; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN A; PHYTOSTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SOLUBILITY; TREATMENT OUTCOME;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; DIGLYCERIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN(A); MALE; MIDDLE AGED; PHYTOSTEROLS; PRAVASTATIN; SOLUBILITY; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 47949119845     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.05.009     Document Type: Article

References (47)

1. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 (1995) 1301-1307
2. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
3. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
4. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (1996) 1001-1009
5. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
6. Miettinen T.A., Strandberg T.E., and Gylling H. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 20 (2000) 1340-1346
7. Nakamura H., Arakawa K., Itakura H., Kitabatake A., Goto Y., Toyota T., et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 368 (2006) 1155-1163
8. Miettinen T.A., Puska P., Gylling H., Vanhanen H., and Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333 (1995) 1308-1312
9. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R., et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78 (2003) 965-978
10. Ostlund Jr. R.E. Phytosterols and cholesterol metabolism. Curr Opin Lipidol 15 (2004) 37-41
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
12. Gylling H., Radhakrishnan R., and Miettinen T.A. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation 96 (1997) 4226-4231
13. Blair S.N., Capuzzi D.M., Gottlieb S.O., Nguyen T., Morgan J.M., and Cater N.B. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am J Cardiol 86 (2000) 46-52
14. Neil H.A., Meijer G.W., and Roe L.S. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 156 (2001) 329-337
15. Cater N.B., Garcia-Garcia A.B., Vega G.L., and Grundy S.M. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am J Cardiol 96 (2005) D23-D28
16. Gylling H., and Miettinen T.A. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients. Atherosclerosis 160 (2002) 477-481
17. Tada N., and Yoshida H. Diacylglycerol on lipid metabolism. Curr Opin Lipidol 14 (2003) 29-33
18. Kondo H., Hase T., Murase T., and Tokimitsu I. Digestion and assimilation features of dietary DAG in the rat small intestine. Lipids 38 (2003) 25-30
19. Taguchi H., Omachi T., Nagao T., Matsuo N., Tokimitsu I., and Itakura H. Dietary diacylglycerol suppresses high fat diet-induced hepatic fat accumulation and microsomal triacylglycerol transfer protein activity in rats. J Nutr Biochem 13 (2002) 678-683
20. Murase T., Aoki M., Wakisaka T., Hase T., and Tokimitsu I. Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. J Lipid Res 43 (2002) 1312-1319
21. Tada N., Watanabe H., Matsuo N., Tokimitsu I., and Okazaki M. Dynamics of postprandial remnant-like lipoprotein particles in serum after loading of diacylglycerols. Clin Chim Acta 311 (2001) 109-117
22. Nagao T., Watanabe H., Goto N., et al. Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men in a double-blind controlled trial. J Nutr 130 (2000) 792-797
23. Teramoto T., Watanabe H., Ito K., Omata Y., Furukawa T., Shimoda K., et al. Significant effects of diacylglycerol on body fat and lipid metabolism in patients on hemodialysis. Clin Nutr 23 (2004) 1122-1126
24. Meguro S., Higashi K., Hase T., et al. Solubilization of phytosterols in diacylglycerol versus triacylglycerol improves the serum cholesterol-lowering effect. Eur J Clin Nutr 55 (2001) 513-517
25. Ministry of Health, Labour and Welfare. The National Nutrition Survey in Japan, 2002 (2002), Ministry of Health, Labour and Welfare, Japan
26. The Ministry of Science & Technology. The Standard Tables of Food Composition in Japan, 4th Revision (1998), The Ministry of Science & Technology, Japan
27. Tilvis R.S., and Miettinen T.A. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 43 (1986) 92-97
28. Miettinen T.A., Tilvis R.S., and Kesaniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131 (1990) 20-31
29. Saito S., Takeshita M., Tomonobu K., Kudo N., Shiiba D., Hase T., et al. Dose-dependent cholesterol-lowering effect of a mayonnaise-type product with a main component of diacylglycerol-containing plant sterol esters. Nutrition 22 (2006) 174-178
30. Thompson P.D., Clarkson P., and Karas R.H. Statin-associated myopathy. JAMA 289 (2003) 1681-1690
31. Liao J.K. Safety and efficacy of statins in Asians. Am J Cardiol 99 (2007) 410-414
32. FDA. Public Health Advisory on Crestor (rosuvastatin), from FDA. Available at: http://www.fda.gov/cder/drug/advisory/crestor_3_2005.htm.
33. Richelle M., Enslen M., Hager C., Groux M., Tavazzi I., Godin J.P., et al. Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans. Am J Clin Nutr 80 (2004) 171-177
34. Law M.R., Wald N.J., and Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326 (2003) 1407-1408
35. Ostlund Jr. R.E., Racette S.B., Okeke A., and Stenson W.F. Phytosterols that are naturally present in commercial corn oil significantly reduce cholesterol absorption in humans. Am J Clin Nutr 75 (2002) 1000-1004
36. Ostlund Jr. R.E., Spilburg C.A., and Stenson W.F. Sitostanol administered in lecithin micelles potently reduces cholesterol absorption in humans. Am J Clin Nutr 70 (1999) 826-831
37. Shin M.J., Lee J.H., Jang Y., Lee-Kim Y.C., Park E., Kim K.M., et al. Micellar phytosterols effectively reduce cholesterol absorption at low doses. Ann Nutr Metab 49 (2005) 346-351
38. Meguro S., Hase T., Otsuka A., Tokimitsu I., and Itakura H. Effect of phytosterols in dietary diacylglycerol on atherosclerosis in cholesterol-fed rabbits. Nutrition 19 (2003) 670-675
39. Goto N., Mori H., Katsuragi H., Toi T., Yasukawa T., and Shimasaki H. Effect of Diacylglycerol containing phytosterol on reducing blood cholesterol level. J Jpn Oil Chem Soc 48 (1999) 235-240
40. Denke M.A. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 61 (1995) 392-396
41. Spilburg C.A., Goldberg A.C., McGill J.B., Stenson W.F., Racette S.B., Bateman J., et al. Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol. J Am Diet Assoc 103 (2003) 577-581
42. Jones P.J., Vanstone C.A., Raeini-Sarjaz M., and St-Onge M.P. Phytosterols in low- and non-fat beverages as part of a controlled diet fail to lower plasma lipid levels. J Lipid Res 44 (2003) 1713-1719
43. Berglund L., and Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 24 (2004) 2219-2226
44. Plat J., and Mensink R.P. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J 16 (2002) 258-260
45. Thomsen A.B., Hansen H.B., Christiansen C., Green H., and Berger A. Effect of free plant sterols in low-fat milk on serum lipid profile in hypercholesterolemic subjects. Eur J Clin Nutr 58 (2004) 860-870
46. Teramoto T., Yamada N., Shimano H., Oka Y., Itakura H., Saito Y., et al. Dose-dependent effect of niceritrol on plasma lipoprotein-a. Scand J Clin Lab Invest 56 (1996) 359-365
47. Beil F.U., Terres W., Orgass M., and Greten H. Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis 90 (1991) 95-97